Swipe om te navigeren naar een ander artikel
Zhuoru Liang and Tiantian Zhang are first authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Hypertension is a major global public health problem, including rural China. However, studies examining health-related quality of life (HRQoL) for patients with hypertension have been mostly conducted in urban populations. This study aimed to use the EuroQol five-dimensional-five-level (EQ-5D-5L) and its recently developed Chinese value set to analyze HRQoL and its influencing factors among hypertensive population in rural China.
This is a cross-sectional population-based survey. Standard interview of participants was conducted from July to September 2016 in Donghai County’s 334 villages of Jiangsu Province, China. Data collection included the EQ-5D-5L, along with sociodemographic characteristics and disease-related factors such as duration of hypertension, antihypertensive treatment and comorbid conditions. The Tobit regression model was employed to analyze potential influencing factors on HRQoL.
A total of 16,596 adults (18 years and older) with hypertension participated in this study. 62.4% were women. The mean utility score was 0.85 (standard deviation [SD] = 0.23). The proportion of participants reporting pain/discomfort problems was highest, while least patients reported problems in self-care dimension. Females, elderly, illiterate patients, ex-smokers and patients with longer duration of hypertension or comorbidities scored lower on HRQoL than others. Stroke, heart failure and coronary heart disease were associated with a larger negative impact on HRQoL among all comorbidities.
The HRQoL was lower in this rural hypertensive population than previously reported urban counterparts. To improve the HRQoL of hypertensive patients in rural areas, it is important to control hypertension and prevent its associated co-morbidities. More attention needs to be directed to elderly female patients with less education who scored much lower HRQoL than their male counterparts.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005). Global burden of hypertension: Analysis of worldwide data. Lancet, 365(9455), 217–223. https://doi.org/10.1016/S0140-6736(05)17741-1.
Ramahi, T. M. (2010). Cardiovascular disease in the Asia Middle East region: Global trends and local implications. Asia-Pacific Journal of Public Health, 22(3 Suppl), 83S–89S. https://doi.org/10.1177/1010539510373034.
Lawes, C. M., Hoorn, S., & Rodgers, A. (2008). Global burden of blood-pressure-related disease, 2001. Lancet, 371(9623), 1513–1518. https://doi.org/10.1016/S0140-6736(08)60655-8.
Lewington, S., Lacey, B., Clarke, R., Guo, Y., Kong, X. L., Yang, L., et al. (2016). The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Internal Medicine, 176(4), 524–532. https://doi.org/10.1001/jamainternmed.2016.0190.
Lu, J., Lu, Y., Wang, X., et al. (2017). Prevalence, awareness, treatment, and control of hypertension in China: Data from 1.7 million adults in a population-based screening study (China PECE Million Persons Project). Lancet 390, 2549–2558.
Li, D., Lv, J., Liu, F., Liu, P., Yang, X., Feng, Y., et al. (2015). Hypertension burden and control in mainland China: Analysis of nationwide data 2003–2012. International Journal of Cardiology, 184, 637–644. https://doi.org/10.1016/j.ijcard.2015.03.045.
Su, M., Zhang Q, Bai, X., et al. (2017). Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: A nationwide cross-sectional survey. Lancet, 390, 2559–2568
Wang, J. G. (2015). Chinese hypertension guidelines. Pulse, 3(1), 14–20. https://doi.org/10.1159/000382025.
Wu, Y., Huxley, R., Li, L., Anna, V., Xie, G., Yao, C., et al. (2008). Prevalence, awareness, treatment, and control of hypertension in China: Data from the China National Nutrition and Health Survey 2002. Circulation, 118(25), 2679–2686. https://doi.org/10.1161/CIRCULATIONAHA.108.788166.
Wang, Z., Liu, R., Li, P., Jiang, C., & Hao, M. (2014). How to make diagnosis related groups payment more feasible in developing countries: A case study in Shanghai, China. Iranian Journal of Public Health, 43(5), 572–578.
The World Health Organization Quality of Life Assessment (WHOQOL). (1998). Development and general psychometric properties. Social Science & Medicine, 46(12), 1569–1585.
Carr, A. J., Gibson, B., & Robinson, P. G. (2001). Measuring quality of life: Is quality of life determined by expectations or experience? BMJ, 322(7296), 1240–1243.
Carr, A. J., & Higginson, I. J. (2001). Are quality of life measures patient centred? BMJ, 322(7298), 1357–1360.
Chen, P. C., Kuo, R. N., Lai, C. K., Tsai, S. T., & Lee, Y. C. (2015). The relationship between smoking status and health-related quality of life among smokers who participated in a 1-year smoking cessation programme in Taiwan: A cohort study using the EQ-5D. British Medical Journal Open, 5(5), e007249. https://doi.org/10.1136/bmjopen-2014-007249.
Cunillera, O., Tresserras, R., Rajmil, L., Vilagut, G., Brugulat, P., Herdman, M., et al. (2010). Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey. Quality of Life Research, 19(6), 853–864. https://doi.org/10.1007/s11136-010-9639-z.
Zhang, L., Guo, X., Zhang, J., Chen, X., Zhou, C., Ge, D., et al. (2017). Health-related quality of life among adults with and without hypertension: A population-based survey using EQ-5D in Shandong, China. Scientific Reports, 7(1), 14960. https://doi.org/10.1038/s41598-017-15083-4.
Zhang, Y., Zhou, Z., Gao, J., Wang, D., Zhang, Q., Zhou, Z., et al. (2016). Health-related quality of life and its influencing factors for patients with hypertension: Evidence from the urban and rural areas of Shaanxi Province, China. BMC Health Services Research, 16, 277. https://doi.org/10.1186/s12913-016-1536-x.
Feng, Y., Devlin, N., & Herdman, M. (2015). Assessing the health of the general population in England: How do the three- and five-level versions of EQ-5D compare? Health Qual Life Outcomes, 13, 171. https://doi.org/10.1186/s12955-015-0356-8.
Nguyen, L. H., Tran, B. X., Le, H., Tran, Q. N., Tran, T., & Latkin, C. A. (2017). Quality of life profile of general Vietnamese population using EQ-5D-5L. Health and Quality of Life Outcomes, 15(1), 199. https://doi.org/10.1186/s12955-017-0771-0.
Xu, R. H., Cheung, A. W. L., & Wong, E. L. (2017). Examining the health-related quality of life using EQ-5D-5L in patients with four kinds of chronic diseases from specialist outpatient clinics in Hong Kong SAR, China. Patient Preference and Adherence, 11, 1565–1572. https://doi.org/10.2147/PPA.S143944.
Liu, L., Li, S., Wang, M., & Chen, G. (2017). Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China. Patient Preference and Adherence, 11, 1049–1056. https://doi.org/10.2147/PPA.S138028.
Luo, N., Liu, G., Li, M., Guan, H., Jin, X., & Rand-Hendriksen, K. (2017). Estimating an EQ-5D-5L value set for China. Value Health, 20(4), 662–669. https://doi.org/10.1016/j.jval.2016.11.016.
Wang, C., Lang, J., Xuan, L., Li, X., & Zhang, L. (2017). The effect of health literacy and self-management efficacy on the health-related quality of life of hypertensive patients in a western rural area of China: A cross-sectional study. International Journal for Equity in Health, 16(1), 58. https://doi.org/10.1186/s12939-017-0551-9.
Tabulation of the 2010 population census of the people’s republic of China. http://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm.
Wang, Z., Chen, Z., Zhang, L., Wang, X., Hao, G., Zhang, Z., et al. (2018). Status of hypertension in China: Results from the China hypertension survey, 2012–2015. Circulation, https://doi.org/10.1161/CIRCULATIONAHA.117.032380.
Liu, L. S. (2011) 2010 Chinese guidelines for the management of hypertension (2011). Chinese Journal of Hypertension. 39(7), 579–615.
Austin, P. C., Escobar, M., & Kopec, J. A. (2000). The use of the Tobit model for analyzing measures of health status. Quality of Life Research, 9(8), 901–910.
Anokye, N. K., Trueman, P., Green, C., Pavey, T. G., & Taylor, R. S. (2012). Physical activity and health related quality of life. BMC Public Health, 12, 624. https://doi.org/10.1186/1471-2458-12-624.
Ahola, A. J., Saraheimo, M., Forsblom, C., Hietala, K., Sintonen, H., Groop, P. H., et al. (2010). Health-related quality of life in patients with type 1 diabetes–association with diabetic complications (the FinnDiane Study). Nephrology Dialysis Transplantation, 25(6), 1903–1908. https://doi.org/10.1093/ndt/gfp709.
Choi, D., Ota, S., & Watanuki, S. (2015). Does cigarette smoking relieve stress? Evidence from the event-related potential (ERP). International Journal of Psychophysiology, 98(3 Pt 1), 470–476. https://doi.org/10.1016/j.ijpsycho.2015.10.005.
Lee, M. H., & So, E. S. (2012). Impact of hypertension-related comorbidity on health-related quality of life: A population-based survey in South Korea. Asia-Pacific Journal of Public Health, 24(5), 753–763. https://doi.org/10.1177/1010539511431822.
Wang, R., Zhao, Y., He, X., Ma, X., Yan, X., Sun, Y., et al. (2009). Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health, 123(8), 534–539. https://doi.org/10.1016/j.puhe.2009.06.009.
Soros, P., Whitehead, S., Spence, J. D., & Hachinski, V. (2013). Antihypertensive treatment can prevent stroke and cognitive decline. Nature Reviews Neurology, 9(3), 174–178. https://doi.org/10.1038/nrneurol.2012.255.
Ye, T., Sun, X., Tang, W., Miao, Y., Zhang, Y., & Zhang, L. (2016). Effect of continuity of care on health-related quality of life in adult patients with hypertension: A cohort study in China. BMC Health Services Research, 16(1), 674. https://doi.org/10.1186/s12913-016-1673-2.
Huo, Y., Li, J., Qin, X., Huang, Y., Wang, X., Gottesman, R. F., et al. (2015). Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: The CSPPT randomized clinical trial. JAMA, 313(13), 1325–1335. https://doi.org/10.1001/jama.2015.2274.
Egan, B. M., Zhao, Y., & Axon, R. N. (2010). US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA, 303(20), 2043–2050. https://doi.org/10.1001/jama.2010.650.
Yoon, S. S., Gu, Q., Nwankwo, T., Wright, J. D., Hong, Y., & Burt, V. (2015). Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension, 65(1), 54–61. https://doi.org/10.1161/HYPERTENSIONAHA.114.04012.
Lu, Y., Wang, P., Zhou, T., Lu, J., Spatz, E. S., Nasir, K., et al. (2018). Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. Journal of the American Heart Association. https://doi.org/10.1161/JAHA.117.007462.
Ho, J. C., Chang, A. M., Yan, B. P., Yu, C. M., Lam, Y. Y., & Lee, V. W. (2012). Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: Experience in Hong Kong. Clinical Cardiology, 35(12), E40–E45. https://doi.org/10.1002/clc.22069.
- Health-related quality of life among rural men and women with hypertension: assessment by the EQ-5D-5L in Jiangsu, China
Alex Z. Fu
- Springer International Publishing
Quality of Life Research
An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation - An Official Journal of the International Society of Quality of Life Research
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649